Skip to content
All Sections
Subscribe Now
62°F
Tuesday, December 24th 2024
Today's E-Edition
Home Page
Close Menu
Business
Technology
Commercial Real Estate
Housing
Marketplace
The Mercury News
SUBSCRIBE NOW
Close Menu
Sign up for email newsletters
Sign Up
Subscribe
Account Settings
Contact Us
Log Out
Spoof a user
Sign up for email newsletters
Sign Up
Subscribe
Search
Silicon Valley
62°F
Tuesday, December 24th 2024
Today's E-Edition
Business
Technology
Commercial Real Estate
Housing
Marketplace
The Mercury News
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Silicon Valley 150
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Prime Medicine, Inc. - Common Stock
(NQ:
PRME
)
2.810
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
2.810
Bid (Size)
2.740 (5)
Ask (Size)
2.850 (3)
Prev. Close
2.810
Today's Range
2.810 - 2.810
52wk Range
2.560 - 9.800
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Prime Medicine Reports Third Quarter 2024 Financial Results and Provides Business Updates
November 12, 2024
From
Prime Medicine, Inc.
Via
GlobeNewswire
Prime Medicine to Participate in Upcoming Investor Conferences
November 06, 2024
From
Prime Medicine, Inc.
Via
GlobeNewswire
Performance
YTD
-67.92%
-67.92%
1 Month
-15.62%
-15.62%
3 Month
-21.94%
-21.94%
6 Month
-54.97%
-54.97%
1 Year
-69.46%
-69.46%
More News
Read More
12 High-Growth Stocks That Could Deliver Parabolic Returns
October 28, 2024
Via
The Motley Fool
Prime Medicine Presents In Vivo Proof-of-Concept Data Highlighting Interim Preclinical Advances in its Wilson’s Disease Program and the Broad Potential of its Universal Liver-Targeted LNP at ESGCT 31st Annual Congress
October 24, 2024
From
Prime Medicine, Inc.
Via
GlobeNewswire
Why I Keep Buying These 14 Incredible Growth Stocks
October 16, 2024
Via
The Motley Fool
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Prime Medicine to Highlight New Preclinical Data, Including In Vivo Data in Wilson’s Disease, at Upcoming Scientific Meetings
October 15, 2024
From
Prime Medicine, Inc.
Via
GlobeNewswire
Why Prime Medicine Stock Soared Nearly 12% Higher on Monday
September 30, 2024
Via
The Motley Fool
Dow Dips 300 Points; Emcore Shares Spike Higher
September 30, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Monday's Intraday Session
September 30, 2024
Via
Benzinga
Crude Oil Moves Higher; Prime Medicine Shares Spike Higher
September 30, 2024
Via
Benzinga
Exposures
Fossil Fuels
Prime Medicine, MINISO Group, Li Auto, Weibo And Other Big Stocks Moving Higher On Monday
September 30, 2024
Via
Benzinga
Prime Medicine Inks Cell Therapy Pact With Bristol Myers Squibb Worth Over $3.5B, Streamlines Pipeline
September 30, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
September 30, 2024
Via
Benzinga
Prime Medicine Unveils Strategically Focused Pipeline
September 30, 2024
From
Prime Medicine, Inc.
Via
GlobeNewswire
Prime Medicine Announces Strategic Research Collaboration and License Agreement with Bristol Myers Squibb to Develop and Commercialize Multiple Prime Edited Ex Vivo T-Cell Therapies
September 30, 2024
From
Prime Medicine, Inc.
Via
GlobeNewswire
2 Growth Stocks That Could Make You Richer
August 28, 2024
Via
The Motley Fool
Prime Medicine to Participate in Upcoming Investor Conferences
August 28, 2024
From
Prime Medicine, Inc.
Via
GlobeNewswire
PRME Stock Earnings: Prime Medicine Misses EPS for Q2 2024
August 08, 2024
Via
InvestorPlace
Prime Medicine Reports Second Quarter 2024 Financial Results and Provides Business Updates
August 08, 2024
From
Prime Medicine, Inc.
Via
GlobeNewswire
Prime Medicine to Present at Upcoming Investor Conferences
May 30, 2024
From
Prime Medicine, Inc.
Via
GlobeNewswire
If You Can Only Buy One Biotech Stock in May, It Better Be One of These 3 Names
May 29, 2024
Via
InvestorPlace
Exposures
Product Safety
Here Are the 2 Growth Stocks Google's Parent Company Just Added to Its $7 Billion Portfolio
May 25, 2024
Via
The Motley Fool
Wall Street Favorites: 3 Cathie Wood Stocks With Strong Buy Ratings for May 2024
May 17, 2024
Via
InvestorPlace
Wall Street Favorites: 3 Biotech Stocks with Strong Buy Ratings for May 2024
May 17, 2024
Via
InvestorPlace
Prime Medicine to Present at H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ
May 13, 2024
From
Prime Medicine, Inc.
Via
GlobeNewswire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Close